Headquartered in San Francisco, California, McKesson Corporation (MCK - Free Report) is a global provider of healthcare supply chain management solutions, retail pharmacy, community oncology cum specialty care, and healthcare information technology.
Currently, McKesson has a Zacks Rank #3 (Hold) but that could change following its fourth quarter fiscal 2018 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here). We have highlighted some of the key details from the just-released announcement below:
Earnings: McKesson’s adjusted earnings of $3.49 per share came below the Zacks Consensus Estimate of $3.54 but increased 2% from the year-ago quarter.
Revenues: McKesson posted sales of $51.62 billion, in line with the Zacks Consensus Estimate for revenues of $51.64 billion. This was up by 3.7% on a year-over-year basis.
Key Stats: The Distribution Solutions segment reported revenues worth $51.6 billion for the quarter, up 5% at constant currency (cc).
Notably, the Technology Solutions segment of the company did not report revenues in the quarter under review.
Major Factors: McKesson expects adjusted earnings per share of $13.00-$13.80 for fiscal 2019.
The guidance range assumes a full-year adjusted tax rate of approximately 21% to 23%, which may vary from quarter to quarter.
Stock Price: Shares have declined 9% in a year’s time, while the industry has gained 7.1% over the same time frame. However, following the earnings release, share prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this McKesson report later!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>